drugset / Trial / NCT03815929
Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women
RandomizedParallel-groupOpen-labelPrevention
Summary
Researchers are trying to assess the appropriate dose of estrogen for decreasing the risk of cardiovascular disease in women who have removal of their ovaries at a young age, before the age of 46 years.
Timeline
- Start
- 2019-03-15
- Primary completion
- 2023-08-28
- Completion
- 2023-08-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Estradiol | Other / unclassified | 100 ug | Other |
| Comparator | Estradiol | Other / unclassified | — | Other |
Indications
No indication recorded.